Erratum: IMpact of medicaid expansion on medicaid-covered utilization of buprenorphine for opioid use disorder treatment (Medical Care (2017) 55 (336–341) DOI: 10.1097/MLR.0000000000000703);Impact of medicaid expansion on medicaid-covered utilization of buprenorphine for opioid use disorder treatment

Medical Care

Volumn 55, Issue 4, 2017, Pages 336-341

  Wen, Hefei ^a   Hockenberry, Jason M ^b   Borders, Tyrone F ^a   Druss, Benjamin G ^b  

^a UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

^b EMORY UNIVERSITY   (United States)

Author keywords

access to care; healthcare reform; Medicaid expansion; opioid abuse

Indexed keywords

BUPRENORPHINE; OPIATE; NARCOTIC ANTAGONIST;

ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DRUG DEPENDENCE TREATMENT; DRUG UTILIZATION; HEALTH CARE POLICY; HUMAN; MAJOR CLINICAL STUDY; MEDICAID; OPIATE ADDICTION; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; RESIDENT; CLINICAL PRACTICE; ECONOMICS; OPIOID-RELATED DISORDERS; STATISTICS AND NUMERICAL DATA; UNITED STATES;

BUPRENORPHINE; DRUG UTILIZATION; HUMANS; MEDICAID; NARCOTIC ANTAGONISTS; OPIOID-RELATED DISORDERS; PRACTICE PATTERNS, PHYSICIANS'; UNITED STATES;

EID: 85015222853     PISSN: 00257079     EISSN: 15371948     Source Type: Journal    
DOI: 10.1097/MLR.0000000000001083     Document Type: Erratum

References (36)

1. Substance Abuse and Mental Health Services Administration (SAMHSA), Center for Behavioral Health Statistics and Quality (CBHSQ). Behavioral health trends in the United States: results from the 2014 National Survey on Drug Use and Health. HHS Publication No. SMA 15-4927, NSDUH Series H-50). Rockville, MD: U.S. Department of Health and Human Services (HHS), SAMHSA; 2015 September. Available at: http://samhsa.gov/data/sites/default/files/NSDUH-FRR1- 2014/NSDUH-FRR1-2014.pdf. Accessed February 29, 2016
2. Rudd RA, Aleshire N, Zibbell JE, et al. Increases in drug and opioid overdose deaths-United States, 2000-2014. Am J Transplant. 2016;16: 1323-1327
3. Rudd RA, Paulozzi LJ, Bauer MJ, et al. Increases in heroin overdose deaths: 28 States, 2010 to 2012. MMWR Morb Mortal Wkly Rep. 2014; 63:849-854
4. U.S. Department of Health and Human Services (HHS), Behavioral Health Coordinating Committee Prescription Drug Abuse Subcommittee. Addressing Prescription Drug Abuse in the United States: Current Activities and Future Opportunities. Washington, DC: HHS; 2013. Available at http://cdc.gov/drugoverdose/pdf/hhs-prescription-drug- abuse-report-09.2013.pdf. Accessed November 28, 2015.
5. Centers for Medicare and Medicaid Services (CMS), Center for Medicaid and CHIP Services (CMCS). Medication-Assisted Treatment for Substance Use Disorders CMS Informational Bulletin on Behavioral Health 07-11-2014. Baltimore, MD: CMS; 2014 Available at http://medicaid.gov/Federal-Policy-Guidance/Downloads/CIB-07-11-2014. pdf. Accessed November 28, 2015.
6. Volkow ND, Frieden TR, Hyde PS, et al. Medication-assisted therapies: tackling the opioid-overdose epidemic. N Engl J Med. 2014;370: 2063-2066
7. Fiellin DA, Pantalon MV, Chawarski MC, et al. Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence. N Engl J Med. 2006;355:365-374
8. Johnson RE, Chutuape MA, Strain EC, et al. A comparison of levomethadyl acetate, buprenorphine, and methadone for opioid dependence. N Engl J Med. 2000;343:1290-1297
9. Fudala PJ, Bridge TP, Herbert S, et al. Office-based treatment of opiate addiction with a sublingual-tablet formulation of buprenorphine and naloxone. N Engl J Med. 2003;349:949-958
10. Stein BD, Pacula RL, Gordon AJ, et al. Where is buprenorphine dispensed to treat opioid use disorders? The role of private offices, opioid treatment programs, and substance abuse treatment facilities in urban and rural counties. Milbank Q. 2015;93:561-583
11. Clinical Tools, Inc. (CTI). DATA 2000 Qualifying Buprenorphine Training at BupPracticecom: buprenorphine training and practice tools: cost of buprenorphine treatment to patients. Chapel Hill, NC: CTI; 2015. Available at: http://buppractice.com/node/12321. Accessed February 29, 2016
12. Mark TL, Levit KR, Vandivort-Warren R, et al. Changes in US spending on mental health and substance abuse treatment, 1986-2005, and implications for policy. Health Aff (Millwood). 2011;30:284-292
13. Garfield RL, Lave JR, Donohue JM. Health reform and the scope of benefits for mental health and substance use disorder services. Psychiatric Serv. 2010;61:1081-1086
14. Kaiser Family Foundation (KFF). Medicaid: A Primer: Key Information on the Nation?s Health Coverage Program for Low-Income People Menlo Park, CA: The Henry J. Kaiser Family Foundation (KFF) The Kaiser Commission on Medicaid and the Uninsured; KFF; 2010. Available at: http://kaiserfamilyfoundation.files.wordpress.com/2010/06/7334-05.pdf. Accessed December 12, 2016
15. Buck JA. The looming expansion and transformation of public substance abuse treatment under the Affordable Care Act. Health Aff (Millwood). 2011;30:1402-1410
16. Busch SH, Meara E, Huskamp HA, et al. Characteristics of adults with substance use disorders expected to be eligible for Medicaid under the ACA. Psychiatric Serv. 2013;64:520-526
17. Cuellar AE, Cheema J. As roughly 700,000 prisoners are released annually, about half will gain health coverage and care under federal laws. Health Aff (Millwood). 2012;31:931-938
18. Bachrach D, Boozang P, Lipson M. Medicaid: States? Most Powerful Tool to Combat the Opioid Crisis. Princeton, NJ: State Health Reform Assistance Network, Robert Wood Johnson Foundation and Manatt Health, Manatt, Phelps & Phillips, LLP; 2016. Available at: http://statenetwork.org/wp-content/uploads/2016/07/State-Network-Manatt- Medicaid-States-Most-Powerful-Tool-to-Combat-the-Opioid-Crisis-July- 2016.pdf. Accessed July 8, 2016.
19. Center for Substance Abuse Treatment. Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs Report No (SMA) 12-4214. Rockville, MD: Substance Abuse and Mental Health Services Administration (SAMHSA); 2005. Available at: http://ncbi.nlm.nih.gov/books/NBK64164/. Accessed July 8, 2016
20. Dick AW, Pacula RL, Gordon AJ, et al. Growth in buprenorphine waivers for physicians increased potential access to opioid agonist treatment, 2002-11. Health Aff (Millwood). 2015;34:1028-1034
21. Jones CM, Campopiano M, Baldwin G, et al. National and state treatment need and capacity for opioid agonist medication-assisted treatment. Am J Public Health. 2015;105:e55-e63
22. Knudsen HK, Lofwall MR, Havens JR, et al. States? implementation of the Affordable Care Act and the supply of physicians waivered to prescribe buprenorphine for opioid dependence. Drug Alcohol Depend. 2015;157:36-43
23. The White House Office of the Press Secretary. Briefing Room Fact Sheet: Obama Administration Announces Additional Actions to Address the Prescription Opioid Abuse and Heroin Epidemic. Washington, DC: The White House; 2013. Available at https://whitehouse.gov/the-pressoffice/2016/03/29/fact-sheet-obama-administration-announces-addition al-actions-address. Accessed March 29, 2016.
24. Centers for Medicare and Medicaid Services (CMS), Center for Medicaid and CHIP Services (CMCS). Medicaid Drug Programs Data and Resources. Baltimore, MD: CMS; 2015 Available at http://medicaid.gov/medicaid-chip-program-information/by-topics/benefits/prescription-drugs/medicaid-drug-programs-data-and-resources.html. Accessed November 28, 2015.
25. Kaiser Family Foundation (KFF), Kaiser Commission on Medicaid and the Uninsured (KCMU). Status of State Action on the Medicaid Expansion Decision. Menlo Park, CA: KFF; 2016. Available at: http://kff.org/health-reform/state-indicator/state-activity-around-expandingmedicaid- under-the-affordable-care-act/. Accessed July 7, 2016
26. Sommers BD, Kenney GM, Epstein AM. New evidence on the Affordable Care Act: coverage impacts of early Medicaid expansions. Health Aff (Millwood). 2014;33:78-87
27. Wooldridge JM. Econometric Analysis of Cross Section and Panel Data. Cambridge, MA: MIT Press; 2010
28. Bertrand M, Duflo E, Mullainathan S. How much should we trust differences-in-differences estimates? Q J Econ. 2004;119:249-275
29. State Health Access Data Assistance Center (SHADAC). Study of the Impact of the ACA Implementation in Kentucky. Minneapolis, MN: SHADAC; 2016 Available at http://healthyky.org/sites/default/files/FINAL%20Quarterly%20Snapshot%20January%202016.pdf. Accessed July 8, 2016.
30. State Health Reform Assistance Network. Medicaid Expansion: Just the Facts. Princeton, NJ: Robert Wood Johnson Foundation; 2016 Available at http://statenetwork.org/wp-content/uploads/2016/03/State- Network-GMMB-Manatt-Medicaid-Expansion-Just-the-Facts-April-2016.pdf. Accessed July 8, 2016.
31. Levey NN. Fighting Obamacare, Many Red States Find Fewer Tools to Fight Opioid Addiction Epidemic. Los Angeles, CA: Los Angeles Times; 2016. Available at: http://latimes.com/nation/la-na-opioidsobamacare- 20160613-snap-story.html. Accessed July 8, 2016
32. Searing A, Hoadley J. Medicaid expansion: driving innovation in behavioral health integration. Health Aff Blog. 2016. Available at: http://healthaffairs.org/blog/2016/07/05/medicaid-expansion-driving-innova tion-in-behavioral-health-integration/. Accessed July 8, 2016
33. Clark E. Beshear: More Opioid Treatment Centers, Funding Needed. Murray, KY: WKMS-FM; 2016. Available at: http://wkms.org/post/beshear-more-opioid-treatment-centers-funding-needed/. Accessed July 8, 2016
34. New York Governor?s Press Office. Governor Cuomo Signs Legislation to Combat the Heroin and Opioid Crisis. Albany, NY: Governor?s Office; 2016 Available at https://governor.ny.gov/news/governor-cuo mo-signs-legislation-combat-heroin-and-opioid-crisis. Accessed July 8, 2016.
35. New Hampshire Department of Health and Human Services (DHHS). New Medicaid Substance Use Disorder Benefits Expand State?s Capacity to Serve Standard Medicaid Recipients. Concord, NH: State DHHS; 2016. Available at: http://dhhs.nh.gov/media/pr/2016/07012016medicaid.htm. Accessed July 8, 2016
36. Substance Abuse and Mental Health Services Administration (SAMHSA). Apply to Increase Patient Limits: New Federal Regulations Increase Limit Rule to 275 Patients. Rockville, MD: SAMHSA; 2016. Available at: https://samhsa.gov/medication-assisted-treatment/bupre norphine-waiver-management/increase-patient-limits. Accessed December 12, 2016